Top Markets
Coin of the day
Dr. Miele Cosmed Group S.A. Dr. Miele Cosmed Group S.A.

Dr. Miele Cosmed Group S.A.

DMG
Rank in Stocks #24835
Dr. Miele Cosmed Group S.A., founded in 1990 and headquartered in Radom,... Dr. Miele Cosmed Group S.A., founded in 1990 and headquartered in Radom, Poland, is actively involved in the global production and distribution of a diverse array of chemical and cosmetic products. Their extensive portfolio includes personal hygiene items such as shower gels, liquid soaps, and sanitizing gels and sprays, alongside a dedicated range for children encompassing washing and care cosmetics, wet wipes, and laundry detergents. The company also manufactures household cleaning essentials, offering toilet cleaners, toilet blocks, drain openers (in granule and gel form), washing liquids, fabric softening concentrates, and specific agents for kitchen and bathroom cleaning, as well as hand and surface disinfectants. These offerings are prominently marketed under brands like Bobini, Apart, Biophen, Mole, Sofin, Izo, and Izozid. The company officially adopted its current name, Dr. Miele Cosmed Group S.A., in March 2024, having previously operated as Global Cosmed S.A.
Share Price
$0.65312925
Market Cap
$56.02M
Change (1 day)
0.00%
Change (1 year)
-34.96%
Country
PL
Trade Dr. Miele Cosmed Group S.A. (DMG)
Revenue for Dr. Miele Cosmed Group S.A. (DMG)
Revenue in Aug 2026 TTM: 0
According to Dr. Miele Cosmed Group S.A. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Dr. Miele Cosmed Group S.A. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$87.03B -
US
$51.67B -
FR
$21.05B -
US
$7.28B -
IN
- -
DE